Tharimmune, Inc. (THAR)
2.79
-0.12
(-4.12%)
USD |
NASDAQ |
Jan 09, 16:00
2.91
+0.12
(+4.30%)
Pre-Market: 08:16
Tharimmune Research and Development Expense (Quarterly): 0.2778M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median